Vesigen to Present New Preclinical Data on Ophthalmology Applications of Engineered ARMMs at 2024 ARVO Annual Meeting CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today ... 05/1/2024 - 4:03 am | View Link
Ora, Inc. to showcase latest technologies and research at ARVO 2024, convene groundbreaking ophthalmic symposium Dry Horizons Just two days before the start of ARVO, Ora will co-present the first-ever Dry Horizons Symposium with Ophthalmology Innovation Source. The inaugural event at the Four Seasons Seattle will unite ... 05/1/2024 - 1:21 am | View Link
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting May 01, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that 14 abstracts, 11 of which are oral presentations, will be presented at the Association for Research ... 04/30/2024 - 8:00 pm | View Link
Companies prepare to unveil research at ARVO 2024 conference More companies have released information on presentations related to their pipelines and new data at the ARVO 2024 conference. 04/30/2024 - 7:49 am | View Link
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting Ocuphire is also developing APX2009 and APX2014, second-generation analogs of APX3330. These programs are being evaluated for treating other retinal diseases such as age-related macular degeneration ... 04/22/2024 - 3:00 am | View Link
The basketball robot programmed to troubleshoot and negate any problem with relative ease encountered a worthy brain-teaser Saturday night.
How does one center adjust to a team that’s able to throw three capable and well-rested bigs at him throughout the course of a game?
Nikola Jokic was actually stumped.
“Have a duplicate clone of myself,” he said finally.
Anthony Edwards is the future, and the evolution was televised Saturday night.
The Nuggets lost for only the second time in their past 15 home playoff games, dropping the opener 106-99 in the Western Conference semifinals. As fans shrugged toward the exits at Ball Arena, one thing was clear: The Minnesota Timberwolves are way better than the whiny Lakers.
First, the obvious.
The Denver Nuggets lost the first game of the second-round NBA playoff series to the Minnesota Timberwolves 106-99 at Ball Arena in Denver, Colorado on Saturday night, May 4, 2024.
Foul trouble is rarely a blessing in disguise.
It might’ve helped the Timberwolves steal a road game in the first chapter of what’s sure to be a bitterly competitive series.
NBA Sixth Man of the Year Naz Reid played prolonged fourth-quarter minutes with Karl-Anthony Towns in foul trouble, and his 10-point burst in the last six minutes handed the Nuggets a 106-99 Game 1 loss on Saturday night.
This is the first time in the last two postseasons that Denver has trailed a series.
Initial thoughts from the Nuggets’ loss to the Minnesota Timberwolves in Game 1 of the Western Conference semifinals on Saturday.
Naz Reid took over in the fourth: Timberwolves forward Naz Reid was named this season’s Sixth Man of the Year for a reason. But how many walked into Ball Arena on Saturday expecting Reid to turn into an All-Star in the fourth?